about
Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials.Contemporary management of high-grade gliomas.Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade.Correlation between lower balance of Th2 helper T-cells and expression of PD-L1/PD-1 axis genes enables prognostic prediction in patients with glioblastoma.The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma.
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Immune Checkpoint Inhibitors in Gliomas.
@en
type
label
Immune Checkpoint Inhibitors in Gliomas.
@en
prefLabel
Immune Checkpoint Inhibitors in Gliomas.
@en
P2860
P1476
Immune Checkpoint Inhibitors in Gliomas
@en
P2093
Amy B Heimberger
P2860
P2888
P356
10.1007/S11912-017-0586-5
P577
2017-04-01T00:00:00Z
P6179
1084033432